paroxetine has been researched along with Cognitive Decline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Garabadu, D; Krishnamurthy, S; Prajapati, SK; Singh, N | 1 |
Baroni, M; Boccardi, V; Ercolani, S; Giordano, M; Longo, A; Mecocci, P; Paolacci, L; Ruggiero, C | 1 |
Li, Y; Lu, X; Tao, C; Yan, W | 1 |
Aparasu, RR; Bali, V; Carnahan, RM; Chatterjee, S; Chen, H; Johnson, ML | 1 |
4 other study(ies) available for paroxetine and Cognitive Decline
Article | Year |
---|---|
A novel stress re-stress model: modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats.
Topics: Animals; Anxiety; Behavior, Animal; Cognitive Dysfunction; Corticosterone; Cues; Depression; Disease Models, Animal; Electric Stimulation; Hypothalamo-Hypophyseal System; Male; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2020 |
Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinergic Antagonists; Cognitive Dysfunction; Cross-Sectional Studies; Female; Hospitalization; Humans; Italy; Longitudinal Studies; Male; Memory; Outpatients; Paroxetine; Risperidone; Trazodone | 2017 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression.
Topics: Aged; Cognitive Dysfunction; Depression; Female; Homes for the Aged; Humans; Male; Nursing Homes; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors | 2016 |